E3 Ubiquitin Protein Ligase Mdm2 Pipeline Review Market H2 2016 E3 Ubiquitin Protein Ligase Mdm2 Market 2016 | Page 11

Pipeline by Amgen Inc., H2 2016 28
Pipeline by Ascentage Pharma Group Corporation, Ltd., H2 2016 29
Pipeline by Daiichi Sankyo Company, Limited, H2 2016 30
Pipeline by F. Hoffmann-La Roche Ltd., H2 2016 31
Pipeline by Merck & Co., Inc., H2 2016 32
Pipeline by Novartis AG, H2 2016 33
Dormant Projects, H2 2016 64
Dormant Projects (Contd..1), H2 2016 65
Dormant Projects (Contd..2), H2 2016 66
Discontinued Products, H2 2016 67
Read Complete Report With TOC @ http://www.radiantinsights.com/research/e3-ubiquitinprotein-ligase-mdm2
List of Figures
Number of Products under Development for, H2 2016 9
Number of Products under Development by Therapy Area, H2 2016 10
Number of Products under Development by Top 10 Indication, H2 2016 11
Comparative Analysis by Late Stage Development, H2 2016 13
Comparative Analysis by Early Stage Products, H2 2016 14
Assessment by Monotherapy/Combination Products, H2 2016 21
Number of Products by Stage and Mechanism of Actions, H2 2016 22
Number of Products by Routes of Administration, H2 2016 23
Number of Products by Stage and Routes of Administration, H2 2016 23
Number of Products by Molecule Types, H2 2016 25
Number of Products by Stage and Molecule Type, H2 2016 25

About Radiant Insights